Welcome to our dedicated page for Verano Hldgs news (Ticker: VRNOF), a resource for investors and traders seeking the latest updates and insights on Verano Hldgs stock.
Verano Holdings Corp. (VRNOF) is a vertically integrated cannabis operator with cultivation, production, and retail facilities across regulated U.S. markets. This page aggregates official announcements, financial disclosures, and strategic developments for stakeholders tracking the company’s progress in the evolving cannabis sector.
Investors will find timely updates on quarterly earnings, regulatory compliance milestones, and expansion initiatives like recent entries into new state markets. All content is sourced directly from company filings and verified media partners to ensure accuracy.
The archive includes press releases covering product launches, partnership agreements, and operational updates. Analytical reports detail Verano’s market positioning through retail footprint growth and brand portfolio development.
Bookmark this page for streamlined access to VRNOF’s latest news. Check regularly for updates on legislative changes impacting operations and the company’s responses to industry trends.
Verano Holdings Corp. (OTCQX: VRNOF) announced it will release its fourth quarter and full year 2021 financial results on April 27, 2022. Furthermore, it is filing for a management cease trade order (MCTO) due to a delay in submitting its 2021 audited financials. The MCTO, if granted, will restrict certain management members from trading the company's securities until the filing is completed. The company will comply with alternative information guidelines and provide bi-weekly updates during this period.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced it will begin personal use cannabis sales in New Jersey on April 21, 2022. The company is the only cannabis operator authorized to sell in New Jersey's central region, with dispensaries in Elizabeth and Lawrence Township. Verano operates 95 dispensaries and 12 cultivation facilities across 13 states, with a cultivation capacity exceeding 1 million square feet. Customers can pre-order products online for same-day pickup or opt for home delivery for medical patients. Business hours are set for both adult and medical cannabis sales.
Verano Holdings Corp. (OTCQX: VRNOF) announced the New Jersey Cannabis Commission's approval of personal use cannabis sales, allowing the company to lead the initial rollout in the state. Verano operates three Zen Leaf dispensaries and a 120,000 sq. ft. cultivation facility in New Jersey, with active operations in 13 states nationwide. Executives expressed optimism regarding economic growth and tax revenue from this move, highlighting a significant moment for the cannabis industry.
On April 6, 2022, Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced the rescheduling of its fourth quarter and full year 2021 financial results, initially set for April 7. The conference call will now take place on April 6 at 6:00 p.m. ET. Verano is a prominent multi-state cannabis operator in the U.S., providing access to regulated cannabis products through its brands like Verano™, Avexia™, and MÜV™. The company operates in 15 states with over 1,000,000 square feet of cultivation capacity.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced the reopening of Zen Leaf Canton at its new location on Cleveland Ave NW on April 4, 2022. The move aims to enhance patient experience with larger space and improved amenities, situated near key local attractions. Ohio's medical cannabis market is expected to generate over $507 million in revenue by 2022. Verano operates five dispensaries in Ohio and has a national footprint across 13 states, with a total of 95 dispensaries and significant cultivation capacity.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced that its executive team will participate in several upcoming cannabis conferences. Highlights include a panel by CIO Aaron Miles at the Green Growth Summit on April 6, and a fireside chat by CEO George Archos at the BTIG Global Cannabis Conference on April 7. The company operates in 15 U.S. states with 12 production facilities, focusing on premium cannabis products under well-known brands like Verano™, Avexia™, Encore™, and MÜV™.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) has opened MÜV Marco Island, the first cannabis dispensary on Marco Island, Florida. Located at 695 Bald Eagle Drive, this new outlet is strategically placed in a shopping district and aims to serve both residents and the influx of tourists, especially given the area's visitor numbers increased to 175,000 in February 2022. MÜV Marco Island offers a broad selection of cannabis products, including edibles and topicals, with an emphasis on patient consultations and online ordering for convenience.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) is set to release its financial results for Q4 and the full year ending December 31, 2021, on April 7, 2022, before markets open. A conference call is scheduled for the same day at 8:30 a.m. ET, where analysts and investors can discuss the results and participate in a Q&A session. Verano is a prominent multi-state cannabis operator in the U.S. with a diverse portfolio, including 12 production facilities and dispensaries across 15 states.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced the grand opening of its 42nd and 43rd MÜV dispensaries in Florida on March 19, 2022. Located in Hillsborough County, MÜV Brandon and MÜV New Tampa aim to provide high-quality medical cannabis to a rapidly growing population. Hillsborough County has seen a significant population increase, adding over 200,000 residents from 2010 to 2020. Verano is committed to enhancing patient experience with online menus and consultations, establishing itself firmly in the Florida cannabis market.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced the grand opening of its first medical cannabis dispensary, Zen Leaf Morgantown, in West Virginia on March 18, 2022. This marks a significant milestone as the state’s medical cannabis market is projected to reach $40 million in sales by 2025. With this new location, Verano expands its footprint to 13 states and 92 dispensaries nationwide, complementing operations in nearby states. Additionally, Verano has permits for a cultivation facility and plans for seven more dispensaries in West Virginia.